Search results
Results from the WOW.Com Content Network
This concept was applied in practice as a procedure known as the Blalock-Thomas-Taussig shunt. The procedure was developed by Alfred Blalock and Vivien Thomas, who were Taussig's colleagues at the Johns Hopkins Hospital. Taussig was partially deaf following an ear infection in childhood; in early adulthood this progressed to full deafness. [2]
When he retired in 1964, he was named a Professor Emeritus of Surgery, as well as a Surgeon-in-Chief Emeritus for Johns Hopkins School of Medicine and Johns Hopkins Hospital. [5] Blalock published more than 200 articles along with a book titled Principles of Surgery, Shock and Other Problems.
Vivien Theodore Thomas (August 29, 1910 [1] – November 26, 1985) [2] was an American laboratory supervisor who, in the 1940s, played a major role in developing a procedure now called the Blalock–Thomas–Taussig shunt used to treat blue baby syndrome (now known as cyanotic heart disease) along with surgeon Alfred Blalock and cardiologist Helen B. Taussig. [3]
The surgery had been designed and first performed on laboratory dogs by Thomas, who taught the technique to Blalock. Although Thomas perfected the technique, he could not perform the surgery because he was not a doctor. The surgery was not completely successful, since Eileen Saxon became cyanotic again a few months later. Another shunt was ...
The first successful operation to treat blue baby syndrome caused by tetralogy of Fallot occurred at Johns Hopkins University in 1944. Through a collaboration between pediatric cardiologist Helen Taussig, surgeon Alfred Blalock, and surgical technician Vivien Thomas, the Blalock-Thomas-Taussig shunt was created. Dr.
In 1964, one day before Blalock's death, he sees Thomas, now a professional instructor of surgeons in the open heart surgery wing. After Blalock's death, Thomas continued his work at Johns Hopkins training surgeons. In a formal ceremony in 1976, Johns Hopkins belatedly recognized the importance of Thomas's work and awarded him an honorary ...
The Blalock–Thomas–Taussig shunt (BTT shunt), [1] previously known as the Blalock–Taussig Shunt (BT shunt), [2] is a surgical procedure used to increase blood flow to the lungs in some forms of congenital heart disease [3] such as pulmonary atresia and tetralogy of Fallot, which are common causes of blue baby syndrome. [3]
At the proximal end, the shunt valve can become blocked due to the buildup of excess protein in the CSF. The extra protein will collect at the point of drainage and slowly clog the valve. The shunt can also become blocked at the distal end if the shunt is pulled out of the abdominal cavity (in the case of VP shunts), or from similar protein ...